0001387131-21-008733.txt : 20210819 0001387131-21-008733.hdr.sgml : 20210819 20210819060120 ACCESSION NUMBER: 0001387131-21-008733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210817 FILED AS OF DATE: 20210819 DATE AS OF CHANGE: 20210819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Collins Cooper C. CENTRAL INDEX KEY: 0001485508 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00100 FILM NUMBER: 211188316 MAIL ADDRESS: STREET 1: 33219 FOREST WEST DRIVE CITY: MAGNOLIA STATE: TX ZIP: 77354 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TherapeuticsMD, Inc. CENTRAL INDEX KEY: 0000025743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870233535 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 YAMATO ROAD, SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 561-961-1900 MAIL ADDRESS: STREET 1: 951 YAMATO ROAD, SUITE 220 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: AMHN, Inc. DATE OF NAME CHANGE: 20090930 FORMER COMPANY: FORMER CONFORMED NAME: CROFF ENTERPRISES INC DATE OF NAME CHANGE: 19970915 FORMER COMPANY: FORMER CONFORMED NAME: CROFF OIL CO DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2021-08-17 0 0000025743 TherapeuticsMD, Inc. TXMD 0001485508 Collins Cooper C. 951 YAMATO ROAD, SUITE 220 BOCA RATON, FL 33431 1 0 0 0 Common Stock 2021-08-17 4 P 0 100000 0.77 A 336864 D Common Stock 2021-08-18 4 P 0 900000 0.72 A 1236864 D The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.746 to $0.78 for an average weighted purchase price of $0.77. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.715 to $0.727 for an average weighted purchase price of $0.72. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Cooper C. Collins 2021-08-19